SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Carotid Artery Disease and Stroke: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara63d466b1

Editorial note
• Last update: 2026-04-23 21:05:26
What is this paper about
This paper shows that carotid-related stroke is not primarily a story of narrowing alone, but of vulnerable plaque biology, hidden high-risk lesions, and smarter individualized selection between medical therapy, surgery, and stenting. The full review is worth reading because it maps where modern carotid care is genuinely shifting, from stenosis percentage toward plaque-driven, multimodal stroke risk stratification.


Abstract: To synthesize multi-modal evidence regarding the pathophysiology, diagnostic biomarkers, and comparative outcomes of surgical and endovascular interventions for carotid-related stroke. The review utilises 1904 original studies with 8515101 total participants (topic deduplicated ΣN). The mapped evidence suggests that carotid-related stroke risk is driven less by luminal narrowing alone and more by plaque vulnerability, particularly intraplaque hemorrhage, inflammation, thrombus, and structural lesions such as carotid web; notably, intraplaque hemorrhage was associated with recurrent ischemic events even in mild-to-moderate stenosis (hazard ratio 2.12), and asymptomatic intraplaque hemorrhage was linked to incident stroke (hazard ratio 2.42). This same pattern is reflected in imaging studies where plaque-based models and morphology outperformed stenosis alone, with reported discrimination around area under the curve 0.74-0.90 in selected cohorts. Across treatment topics, carotid endarterectomy remained the benchmark for symptomatic high-grade stenosis, while transcarotid artery revascularization emerged as a promising alternative with low reported 30-day stroke or death rates around 0.8%-2.3% in prospective and registry studies; by contrast, contemporary medically treated asymptomatic stenosis cohorts often showed annual stroke risks below 1%. Clinically, the evidence map supports moving from a stenosis-only framework toward multimodal risk stratification that integrates plaque biology, symptom status, and procedural context when selecting medical therapy, surgery, or stenting. Future research should prioritize standardized prospective validation of plaque-based imaging and biomarker strategies, along with comparative trials in nonstenotic but high-risk carotid disease phenotypes.

Keywords: Carotid artery stenosis; Acute ischemic stroke; Carotid plaque; Non-stenotic carotid disease; Carotid endarterectomy; Intraplaque hemorrhage; Embolic stroke of undetermined source; Carotid revascularization; Intraluminal carotid thrombi; Vulnerable plaque

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (252)